Two Additional Phase I Studies in Lung and Esophageal Cancer Pending
NANOBIOTIX Announces First Patient Injected with NBTXR3 in Pancreatic Cancer and Safe to Proceed Notifications for Two Additional Trials From U.S. FDA
Two Additional Phase I Studies in Lung and Esophageal Cancer Pending